key: cord-0912347-opckeugf authors: Lednicky, John A.; Lauzardo, Michael; Hugh Fan, Z.; Jutla, Antarpreet; Tilly, Trevor B.; Gangwar, Mayank; Usmani, Moiz; Shankar, Sripriya Nannu; Mohamed, Karim; Eiguren-Fernandez, Arantza; Stephenson, Caroline J.; Alam, Md. Mahbubul; Elbadry, Maha A.; Loeb, Julia C.; Subramaniam, Kuttinchantran; Waltzek, Thomas B.; Cherabuddi, Kartikeya; Glenn Morris, J.; Wu, Chang-Yu title: Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients date: 2020-09-16 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2020.09.025 sha: 3fb316cd0a284a100fbfdcd632e6c45be9e71184 doc_id: 912347 cord_uid: opckeugf OBJECTIVES: Because detection of SARS-CoV-2 RNA in aerosols but failure to isolate viable (infectious) virus are commonly reported, there is substantial controversy whether SARS-CoV-2 can be transmitted through aerosols. This conundrum occurs because common air samplers can inactivate virions through their harsh collection processes. We sought to resolve the question whether viable SARS-CoV-2 can occur in aerosols using VIVAS air samplers that operate on a gentle water-vapor condensation principle. METHODS: Air samples collected in the hospital room of two COVID-19 patients, one ready for discharge, the other newly admitted, were subjected to RT-qPCR and virus culture. The genomes of the SARS-CoV-2 collected from the air and isolated in cell culture were sequenced. RESULTS: Viable SARS-CoV-2 was isolated from air samples collected 2 to 4.8 m away from the patients. The genome sequence of the SARS-CoV-2 strain isolated from the material collected by the air samplers was identical to that isolated from the newly admitted patient. Estimates of viable viral concentrations ranged from 6 to 74 TCID(50) units/L of air. CONCLUSIONS: Patients with respiratory manifestations of COVID-19 produce aerosols in the absence of aerosol-generating procedures that contain viable SARS-CoV-2, and these aerosols may serve as a source of transmission of the virus. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), genus Betacoronavirus, subgenus integrity for up to 16 hours in laboratory-created respirable-sized aerosols. Nevertheless, finding virus RNA in material collected by an air sampler may not correlate with risk. Indeed, the air we breathe is full of viruses (animal, plant, bacterial, human, etc.), yet a large proportion of the viruses in air are non-viable due to UV-inactivation, drying, etc., and non-viable viruses cannot cause illnesses. Because efforts to isolate virus in cell cultures in the aforementioned air sampling studies in hospital wards were not made (Guo et al., 2020; Chia et al., 2020) , or failed when they were attempted due to overgrowth by faster J o u r n a l P r e -p r o o f replicating respiratory viruses (Lednicky et al., 2020) , and so far only one has provided evidence of virus isolation (Santarpia et al., 2020) , uncertainties about the role of aerosols in COVID-19 transmission remain. It is well known that virus particles collected by various air samplers become inactivated during the air sampling process (Pan et al., 2019) , and if such is the case for SARS-CoV-2, this partly explains why it has been difficult to prove that SARS-CoV-2 collected from aerosols is viable. Because we previously collected SARS-CoV-2 from the air of a respiratory illness ward within a clinic but were unable to isolate the virus in cell cultures due to out-competition by other respiratory viruses (Lednicky et al., 2020) , we sought to perform air sampling tests in a hospital room reserved for COVID-19 patients, to lessen the probability of collecting other airborne human respiratory viruses. We thus collected aerosols containing SARS-CoV-2 in a room housing COVID-19 patients using our VIVAS air samplers that collect virus particles without damaging them, thus conserving their viability. These samplers operate using a water- Additional details are provided in the Supplementary file that accompanies this article. An abbreviated description of the methods used for this work is provided below: Patient 1 had coronary artery disease and other co-morbidities, and after respiratory illness of two-days duration, was transferred from a long-term care facility for COVID-19 treatment the evening before our air sampling tests were initiated. On admission, a nasopharyngeal (NP) swab from the patient was rRT-J o u r n a l P r e -p r o o f PCR positive for SARS-CoV-2 RNA (Cq = 32). Patient 2 had been admitted four days before the air sampling tests with a mid-brain stroke; the patient had a positive NP swab test for SARS-CoV-2 on admission, but a repeat test was negative, and the patient was in the process of being discharged at the time the air sampling was being done. Both patients provided written consent for this study. Air samples were collected in a room that was part of a designated COVID-19 ward (Figure 1 ). The room had six air changes per hour and the exhaust air underwent triple filter treatment (minimum efficiency reporting value [MERV] 14, 75%-85% efficiency for 0.3 µm particles), coil condensation (to remove moisture), and UV-C irradiation prior to recycling 90% of the treated air back to the room. Three serial 3-hr air samplings were performed using our prototype VIVAS air sampler ( Table 1 that detect a section of the SARS-CoV-2 N-gene (Lednicky et al., 2020) . The N-gene rRT-PCR assay that was J o u r n a l P r e -p r o o f used was part of a dual (N-and RdRp-gene) rRT-PCR assay designed by J. Lednicky and does not detect common human alpha-or beta-coronaviruses. Using this particular N-gene rRT-PCR detection system, the limit of detection is about 1.5 SARS-CoV-2 genome equivalents per 25 µL rRT-PCR assay. Cell lines used for the isolation of SARS-CoV-2 were obtained from the American Type Culture Collection (ATCC) and consisted of LLC-MK2 (Rhesus monkey kidney cells, catalog no. ATCC CCL-7) and Vero E6 cells (African green monkey kidney cells, catalog no. ATCC CRL-1586). Cells grown as monolayers in a T-25 flask (growing surface 25 cm 2 ) were inoculated when they were at 80% of confluency. First, aliquots (100 µL) of the concentrated air sampler collection media were filtered through a sterile 0.45 µm pore-size PVDV syringe-tip filter to remove bacterial and fungal cells and spores. Next, the spent LLC-MK2 and Vero E6 cell culture medium was removed and replaced with 1 mL of cell culture medium, and the cells inoculated with 50 μL of cell filtrate. When virus-induced cytopathic effects (CPE) were evident, the presence of SARS-CoV-2 was determined by rRT-PCR. The number of viral genome equivalents present in each sample was estimated from the measured quantification cycle (Cq) values. To do so, a 6-log standard curve was run using 10-fold dilutions of a calibrated plasmid containing an insert of the SARS-CoV-2 N-gene that had been obtained from IDT Technologies, Inc. (Coralville, Iowa). The data was fit using equation (eq.) 1: Eq. 1. y = (log10GE)(a) + b, where y = Cq value, a = slope of the regression line, log10GE is the base 10 log genome equivalents, and b is the intercept of the regression line. To obtain the virus consensus sequence prior to possible changes that might occur during isolation of the virus in cell cultures, a direct sequencing approach was used. Because the amount of virus present in the samples was low and thus unsuitable for common next-generation sequencing approaches, Sanger J o u r n a l P r e -p r o o f sequencing based on a gene-walking approach with non-overlapping primers was used to obtain the virus sequence (Lednicky et al., 2020). The vRNA extracted from virions in spent Vero E6 cell culture medium served as a template to generate a cDNA library using a NEBNext Ultra II RNA Library Prep kit (New England Biolabs, Inc.). Sequencing Whereas the concentration of SARS-CoV-2 genome equivalents per liter of air were estimated ( Table 2 ), determination of the specific infectivity (ratio of SARS-CoV-2 genome equivalents present for every one able to infect a cell in culture) required performance of a plaque assay or a standard 50% endpoint dilution assay (TCID50 assay). Plaque assays could not be performed due to a nationwide non-availability of some critical media components (due to COVID-19 pandemic-related temporary lockdown of production facilities), so TCID50 assays were performed in Vero E6 cells to estimate the percentage of the collected virus particles that were viable. Estimates ranged from 2 to 74 TCID50 units/L of air (Table 4) . A nearly complete SARS-CoV-2 genome sequence was obtained by next-generation sequencing (NGS) of RNA purified from cell culture medium of Vero E6 cells 7 dpi with NP swab material from patient 1. The RNA that was used for NGS had an rRT-PCR Cq value of 14 when tested using the SARS-CoV-2 Ngene primers described in Table 1 . The nearly complete genome sequence (and the virus isolate) were designated SARS-CoV-2/human/UF-19/2020, and this genome sequence has been deposited in GenBank (accession no. MT668716) and in GISAID (accession no. EPI_ISL_480349). Because the amount of virus RNA was below the threshold that could be easily sequenced by our NGS methods, Sanger sequencing was used to sequence SARS-CoV-2 RNA directly purified from the collection media of air samplers 1-1, 1-3, 2-1, and 2-3. One complete SARS-CoV-2 sequence was attained for RNA purified in the material collected by air sampling 1-1, and three nearly complete sequences for 1-3, 2-1, and 2-3, respectively. There are substantial epidemiologic data supporting the concept that SARS-CoV, which is highly related reports, uncertainties remain about the relative importance of aerosol transmission of SARS-CoV-2, given that so far, only one study has provided weak evidence of virus isolation from material collected by air samplers (Santarpia et al., 2020) . In other reports, attempts to isolate the virus were not successful. The current study takes advantage of a newer air sampling technology that operates using a water-vapor condensation mechanism, facilitating the likelihood of isolating the virus in tissue culture. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors proclaim they have no conflicts of interest to report. Tables a This TaqMan® probe is 5'-end labeled with the reporter molecule 6-carboxyfluorescein (FAM) and with quencher Black Hole Quencher 1 (BHQ-1) at the 3'-end. The proximal origin of SARS-CoV Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding The Lancet Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndromerelated coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2 Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia Clinical Characteristics of Coronavirus Disease 2019 in China An emerging coronavirus causing pneumonia outbreak in Wuhan, China: Calling for developing therapeutic and prophylactic strategies Emerg Microbes Infect A novel coronavirus from patients with pneumonia in China SARS-CoV-2 productively infects human gut enterocytes Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals Detection of SARS-CoV-2 in different types of clinical specimens First case of 2019 novel coronavirus in the United States Evidence for gastrointestinal infection of SARS-CoV-2 World Health Organization. Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations: scientific brief Frequently asked questions High SARS-CoV-2 attack rate following exposure at a choir practice -Skagit County Airborne transmission of SARS-CoV-2: The world should face the reality Transmission of COVID-19 virus by droplets and aerosols: a critical review on the unresolved dichotomy COVID-19 may transmit through aerosol Rapid expert consultation on the possibility of bioaerosol spread of SARS-CoV-2 for the COVID-19 pandemic Aerosol and surface distribution of severe acute respiratory syndrome coronavirus 2 in hospital wards Aerosol and surface transmission potential of SARS-CoV-2 observed in quarantine Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients Collection of SARS-CoV-2 virus from the air of a clinic within a university student health care center and analyses of the viral genome Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1 Persistence of severe acute respiratory syndrome coronavirus 2 in aerosol suspensions Collection, particle sizing and detection of airborne viruses Highly efficient collection of infectious pandemic influenza H1N1 virus (2009) through laminar-flow water based condensation Collection of viable aerosolized influenza virus and other respiratory viruses in a student health care center through water-based condensation growth mSphere Improved metagenomic analysis with Kraken SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing Evidence of airborne transmission of the severe acute respiratory syndrome virus Multi-zone modeling of probable SARS virus transmission by airflow between flats in block E Environmental transmission of SARS at Amoy Gardens Coronavirus disease outbreak in call center It is Time to Address Airborne Transmission of COVID-19 The authors thank Dr. Katherine Deliz (UF Environmental Engineering Sciences) for access to her necessarily represent the official views of the National Science Foundation and the National Institutes of Health. The study protocol was approved by the UF IRB (study IRB202002102).